French Aerospace & Defense Stock News

Exail Technologies (ENXTPA:EXA) is in focus after reporting full year 2025 earnings, with sales of €502.83 million and net income of €2.98 million, compared with a net loss a year earlier. See our latest analysis for Exail Technologies. Against this backdrop, Exail Technologies' 7 day share price return of 15.83% and 90 day share price return of 76.37% suggest momentum has been building. A 1 year total shareholder return of more than 3x points to a strong longer term payoff for investors who...

Recent performance context for Pernod Ricard Pernod Ricard (ENXTPA:RI) has drawn investor attention after a weak share price spell, with the stock showing negative returns over the past month, past 3 months and year, despite reporting annual revenue of €10,036 and net income of €1,411. See our latest analysis for Pernod Ricard. At a share price of €64.52, the recent 30 day share price return of 21.03% decline and 1 year total shareholder return of 28.45% loss point to fading momentum and...

Wondering if North Atlantic Energies at €70.15 is still offering value after its strong run, or if most of the opportunity is already reflected in the price. The stock has delivered returns of 24.4% over the past week, 69.4% over the past month, 55.6% year to date and 91.7% over the past year, so recent price action is likely front of mind for many investors. Recent coverage has focused on the company’s position in the energy sector and investor interest in its growth story, with share price...

What Sanofi’s recent share performance tells you Sanofi (ENXTPA:SAN) has seen relatively flat movement over the past month, while returns over the past 3 months and year sit in negative territory. That combination naturally raises questions about how investors view the current €78.15 share price. See our latest analysis for Sanofi. Short term momentum has picked up, with a 1-day share price return of 2.67% and 7-day share price return of 2.13%. However, the 1-year total shareholder return of...

The public roll out of the Falcon 10X positions Dassault Aviation société anonyme (ENXTPA:AM) at the center of attention as investors assess what this flagship business jet could mean for the stock. See our latest analysis for Dassault Aviation société anonyme. Despite the Falcon 10X roll out drawing fresh attention, Dassault Aviation société anonyme’s share price has eased slightly in the very short term, with a 1 day share price return of a 2.13% decline and a 7 day share price return of a...

Voltalia (ENXTPA:VLTSA) is back in focus after full year 2025 results showed sales of €588 million versus €520 million a year earlier, alongside a net loss of €128 million versus €21 million. See our latest analysis for Voltalia. The latest full year results seem to have sharpened attention on profitability, with the share price at €6.835 and a 7 day share price return of 7.47% contrasting with a year to date share price return of 16.29% decline and a 3 year total shareholder return of 51.66%...

Virbac (ENXTPA:VIRP) has put fresh numbers on the table for FY 2025, reporting second half revenue of €726.4 million and net income of €68.5 million, while the trailing twelve month figures stand at €1.46 billion of revenue and €150.9 million of net income. The company’s revenue has moved from €694.4 million and net income of €50.6 million in 2024 H2 to €726.4 million and €68.5 million in 2025 H2. This comes alongside trailing EPS of €15.88 and sets up a story where investors will be weighing...

BNP Paribas (ENXTPA:BNP) has set out a multi year plan for its asset management arm that targets higher pre tax income, larger net inflows and deeper use of the recently acquired AXA Investment Managers platform. See our latest analysis for BNP Paribas. Recent announcements around the asset management plan, the integration of AXA Investment Managers and fresh fixed income issuance sit against a share price of €87.3, with a 90 day share price return of 8.8% and a 1 year total shareholder...

Sartorius Stedim Biotech (ENXTPA:DIM) has outlined expectations for annual organic growth of 8% to 11% from 2027, underlining management’s focus on both top-line expansion and profitability, a message that investors are now weighing. See our latest analysis for Sartorius Stedim Biotech. The new long term growth outlook comes after a mixed run for investors, with a 7 day share price return of 7.12% and a 10.86% decline in the 1 year total shareholder return. This suggests momentum is...

For investors wondering whether Elis at €25.64 offers good value or whether the easier gains may have passed, this article walks through what the current price implies for you as a shareholder. The stock has delivered 7.6% year to date and 16.8% over the last year, as well as a 57.8% return over three years and 99.5% over five years. Recent coverage has highlighted Elis as a key player in commercial services in France and Europe, with particular attention on how it manages contracts,...

Kering (ENXTPA:KER) has created Kering Jewelry as a dedicated division for its jewelry activities. The new division consolidates the group’s jewelry brands and related industrial capabilities. Kering has appointed new leadership to run the unit and reorganized its reporting into new operating segments. Kering, through ENXTPA:KER, is known for luxury brands across fashion, leather goods, and accessories, and jewelry is now getting its own dedicated structure. By grouping its jewelry houses...

Latest FY 2025 headline numbers Exail Technologies (ENXTPA:EXA) has just posted FY 2025 second half revenue of €272.0 million with basic EPS of €0.098, while trailing twelve month revenue stands at €502.8 million and EPS at €0.176. The company has seen revenue move from €222.5 million and basic EPS of €0.004 in the second half of FY 2024 to €230.8 million and €0.077 in the first half of FY 2025, before reaching the latest levels. This signals that higher sales are now flowing through more...

Valneva (ENXTPA:VLA) has just posted its FY 2025 numbers with Q4 revenue of €47.7 million, a basic EPS loss of €0.28, and net income loss of €50.0 million, keeping the focus firmly on how fast the top line can support the still negative bottom line. Over the past two reported fourth quarters, revenue has moved from €52.9 million in FY 2024 to €47.7 million in FY 2025. Trailing twelve month revenue sits at €174.7 million against a trailing EPS loss of €0.68 and a net income loss of €115.2...

AI data center push puts Schneider Electric in focus Schneider Electric (ENXTPA:SU) has moved further into the AI data center space, unveiling new power and cooling validation tools, digital twin integrations, and AI based alarm management alongside NVIDIA and AVEVA. These AI Factory focused solutions target gigawatt scale facilities where energy efficiency, reliability and faster deployment are central to long term investment cases in digital infrastructure. See our latest analysis for...

TotalEnergies recently shut down or began shutting down production in Qatar, Iraq and offshore UAE due to regional conflict, affecting about 15% of its global output and around 10% of upstream cash flow, while continuing operations in onshore UAE and at the Satorp refinery in Saudi Arabia. At the same time, the company has brought new projects online in Angola, Libya and Brazil, helping to support LNG supply and oil production even as geopolitical tensions disrupt part of its Middle East...

Bolloré (ENXTPA:BOL) has just posted its FY 2025 numbers with first half revenue of €1,547.4 million and basic EPS of €0.08, against a backdrop where reported earnings over the last 12 months rose 133.2% and the net profit margin moved from 4.5% to 11.3%. Over recent periods, revenue has shifted from €1,540.7 million in the first half of 2024 to €1,547.4 million in the first half of 2025. Basic EPS moved from a loss of €0.03 in early 2024 to €0.08 in the latest half and €0.16 on a trailing 12...

Recent price performance and what it might signal Arkema (ENXTPA:AKE) has drawn attention after a recent 4.9% one day share price decline, extending a month fall of 14.5% while the past 3 months show a modest positive total return. This mix of shorter term weakness and recent quarter resilience is prompting investors to reassess how Arkema's €9,068.0m revenue base and €39.0m net income align with the current €53.45 share price. See our latest analysis for Arkema. Set against a 2.1% year to...

Compagnie de l'Odet (ENXTPA:ODET) has just posted its FY 2025 numbers with first half revenue of €1,546.7 million and basic EPS of €35.38, set against trailing twelve month EPS of €267.94 and revenue of €11.7 billion. Over the past year, the company has seen revenue move from €1,539.7 million in the first half of FY 2024 and €3,128.7 million in the second half to €3,135.7 million in the latest trailing period, while EPS shifted from losses of €489.29 and €155.73 per share to positive €267.94,...

HSBC’s recent report on luxury stocks put Hermès International Société en commandite par actions (ENXTPA:RMS) in focus, highlighting retail expansion, pricing attention, and U.S. demand as key drivers in its upgraded view. See our latest analysis for Hermès International Société en commandite par actions. Hermès shares have pulled back recently, with a 30 day share price return of a 14.18% decline and a 1 year total shareholder return of a 23.80% decline. This contrasts with a 5 year total...

Air France-KLM (ENXTPA:AF) is back in focus after suspending flights to Tel Aviv, Beirut, Dubai, Riyadh and Dammam following recent conflict in Iran. This move directly affects traffic, route mix and revenue visibility. See our latest analysis for Air France-KLM. The share price has slipped in recent months, with a 30 day share price return of 17.39% and a year to date share price return of 21.03%, while the 1 year total shareholder return of 3.73% and 5 year total shareholder return of...

Without a specific news event driving headlines, AXA (ENXTPA:CS) is drawing interest as investors weigh recent share performance, dividend prospects, and the scale of its global insurance and asset management operations. See our latest analysis for AXA. At a share price of €39.18, AXA has seen a 4.59% 1 month share price return but a 4.32% decline year to date, while its 5 year total shareholder return of 135.25% reflects a very strong longer term outcome. If AXA’s recent moves have you...

BNP Paribas (ENXTPA:BNP) has outlined a 2030 plan for its Asset Management arm, aiming to scale operations and nearly double pre tax profit. The plan is backed by the integration of AXA Investment Managers and a focus on private credit and alternative assets. Management positions the Asset Management platform as a central growth driver for the wider BNP Paribas group. For you as an investor, this update centers on how BNP Paribas wants its Asset Management business to contribute within the...

If you are wondering whether 74Software at €32.40 is still offering value or starting to look fully priced, the next sections will help you frame that question more clearly. The stock has been volatile recently, with a 3.6% decline over the last week, a 20.0% return over the last 30 days, a 21.9% decline year to date, and a 6.2% return over the last year, which can change how you think about both opportunity and risk. That price action has put 74Software back on many investors' watchlists,...

Valeo (ENXTPA:FR) is back in focus after partner Scalvy reported a successful concept evaluation of its battery integrated Power Neuron architecture in a Valeo built automotive system under WLTC test conditions. See our latest analysis for Valeo. The Scalvy partnership update lands after a weak 30 day share price return of a 21.8% decline and a year to date share price return of a 14.45% decline, while the 1 year total shareholder return is 8.71%. Recent momentum has softened even as longer...